Ofinext 100% part of the Ofichem Group 03 Aug 2020
Last year, Lab Ofichem set up a new Business Unit, Ofinext, through a joint venture. We can now announce that Ofinext has been completely taken over by Lab Ofichem and has therefore become a 100% part of the Ofichem Group.
Full Spectrum Cannabis Extracts
Ofinext is fully engaged in producing full spectrum cannabis extracts as an Active Pharmaceutical Ingredient (API) for the pharmaceutical industry. The extract is obtained using a unique extraction technology under GMP guidelines. The technique allows valuable ingredients of the plant to be retained in the extract after the process. This is in contrast to other common extraction techniques.
“We consider it important to continue investing in this. We are therefore delighted with this strategic step and acquisition of the 100% shares.” – Weite Oldenziel, CEO Ofichem Group.
No noticeable changes
This acquisition does not bring any noticeable changes to customers as production has already taken place at our GMP and FDA approved production facility in Ter Apel (the Netherlands). We, as a developer, producer, distributor and laboratory for API’s, remain the trusted address for medicinal full spectrum cannabis extracts and guarantee the service you are used from us.
For information about Ofinext and our cannabis extracts please contact email@example.com or Alessia Cogotti, Managing Director Lab Ofichem.